Your SlideShare is downloading. ×

Infographic: The Bottleneck in Patient Recruitment

428

Published on

The growth rate of compounds in development far exceeds population growth and the number of investigators remains mostly flat. Because of this, patient recruitment for clinical trials functions as a …

The growth rate of compounds in development far exceeds population growth and the number of investigators remains mostly flat. Because of this, patient recruitment for clinical trials functions as a bottleneck in the process. The industry has to increase its focus on Patient Recruitment. Copyright Industry Standard Research.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
428
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
15
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. The growth rate of compounds in development far exceeds population growth and the number of investigators remains mostly flat. Because of this, patient recruitment for clinical trials functions as a in Patient Recruitment bottleneck in the process. The industry has to increase its focus on Patient Recruitment. PrioritiesFaster patient recruitment leads to fewer delays in clinical trials, which means getting drugs on the shelf quicker. Sowhy do only 2% of sponsors rank patient recruitment strategy as the most important when selecting a service provider? What would 30% lower costs mean? 47% $1.5-$2M 18-24 months $1,111/day Cost of an average Length of an average 30% savings of an average Phase II Study. Phase II Study. Phase II Study.of clinical developmentdecision-makers would vs. prefer a 30% lower clinical trial cost than 10% faster patient recruitment What would 10% faster patient $1,885,000/day recruitment mean? Revenue generated per day by The 100th best selling drug in 3Q2012 (Stelara) ViewpointsClinical trials involve five main groups, each with different views and motivations. Here’s what they’re sayingabout clinical trials: 69% 28% 76% 70% 233% said they have not said that inclusion/exclusion said they are involved in said the hardest part of increase in patients participated in clinical criteria have the single the right amount, or too patient recruitment is required per NDA from trials because they biggest impact on patient many clinical trials. finding the 1500 in the 1970s to were not made aware recruitment success. right investigators. more than 5000 today. of any trials. Patients Site Coordinators Investigators Sponsors FDA Implications 11% 37% 39% 13% of sites in a given trial fail of sites in a given trial of sites in a given trial meet of sites in a given trial to enroll a single patient under-enroll their enrollment targets exceed their targetsThe patient recruitment methods with the highest value, tend to be the more traditional methods: Dr. Referral Mail from Doctor Custom Website Local Newspaper Radio Poster in Doctor’s Office Affinity Groups sources: clinicaltrials.gov, Tufts, ISR Reports Data Copyright 2013 Industry Standard Research | ISRreports.com | info@ISRreports.com

×